Fifty-Seven Capital

InvestorScreen: DoneContacts: To Do

Description

Welcome to Fifty-Seven Capital, our team is a dynamic combination of experienced entrepreneurs and private equity sponsors, united by a shared passion for driving growth and success. We are actively seeking to acquire a manufacturing business or value-added distribution business in four strategic industries: Specialty Components: Critical components for energy, aerospace, defense, medical, robotics, and OEM products. Specialty Chemicals: Advanced chemicals for biotechnology, plastics, hydrogen, fuels, coatings, paints, cleaning chemicals, disinfectants, and raw materials for the food, beverage, health, and beauty industries. Our target investments have an EBITDA from 3M to 15M and an Enterprise value: 10M to 100M. At Fifty-Seven Capital, we help business owners create a seamless succession plan, ensuring a smooth transition for their legacy. Join us in shaping the future of innovative industries.

AI Sector Summary

Fifty-Seven Capital is an independent sponsor targeting manufacturing and value-added distribution businesses in the specialty components and chemicals sectors with EBITDA between $3M and $15M.

Location

San Antonio, Texas, United States

Industry

Venture Capital and Private Equity Principals

Investor Type

pe, independent sponsor

Target Sectors

manufacturing, wholesale & distribution, energy, aerospace, defense, medical, robotics, chemicals, food & drink

Verticals

Industrial / Manufacturing

Financials

Revenue

$30

EBITDA

$9

Employees

2

Founded

Sectors (from search)

industrial_manufacturing, food_beverage · specialty components, energy, aerospace, defense, medical, robotics, specialty chemicals, biotechnology, plastics, hydrogen, fuels, coatings, cleaning chemicals, food and beverage raw materials, value-added distribution

Classify Status

Done

Prospects

0 people

No prospects linked to this account.

Outreach History

Outreach sequencing tables are not yet in Supabase.

ID: 5463Airtable: recfB6qGtrFlE2Oc9Created: 10/04/2026